KSE - Delayed Quote KRW

NH Investment & Securities Co., Ltd. (005945.KS)

15,340.00

0.00

(0.00%)

At close: 3:30:30 PM GMT+9

ImmunoForge Receives IND Approval for Phase 2 Clinical Trial of 'Pemziviptadil' for DMD Cardiomyopathy Treatment from FDA, and KF1601, a chronic myeloid leukemia treatment, phase 1 clinical trial IND approved by MFDS

ImmunoForge announced that it has received approval for the Phase 2 clinical trial IND for 'Pemziviptadil (development code name PF1804),' a treatment for DMD (Duchenne Muscular Dystrophy) cardiomyopathy, from the U.S. Food and Drug Administration (FDA).

PR Newswire 4 months ago

005940.KQ

005940.KS

005945.KQ
UNLIMEAT Kimbap Products Now Available via DoorDash's DashMart

Frozen kimbap has become extremely popular lately – it's flying off the shelves and has become a new sensation in Korean cuisine. If you're a kimbap fan, you no longer need to worry about it being sold out. UNLIMEAT recently announced that they've launched their frozen kimbap on DashMart. DashMart is a new type of online convenience store operated by DoorDash that delivers groceries, everyday essentials, and local products. Thanks to entering DashMart, UNLIMEAT can now sell their kimbap nationwi

PR Newswire 11 months ago

005940.KS

005945.KS
0.00%

Performance Overview

Return	005945.KS	KOSPI Composite Index (^KS11)
YTD	+36.39%	+12.43%
1-Year	+49.69%	+2.36%
3-Year	+83.35%	+1.05%